POSTTRANSPLANT CYCLOPHOSPHAMIDE-BASED HAPLOIDENTICAL TRANSPLANTATION, WITH MMF 30 MG/KG, COMPARED WITH UNRELATED DONOR TRANSPLANTATION WITH ATG 6 MG/KG, WITH BONE MARROW OR PERIPHERAL BLOOD STEM CELL GRAFTS LJ Arcuri; SPC Maradei; SP Lermontov; D Lerner; CO Ribeiro;

POSTTRANSPLANT CYCLOPHOSPHAMIDE OR ANTI-THYMOCYTE GLOBULIN FOR UNRELATED DONOR HEMATOPOIETIC CELL TRANSPLANTATION LJ Arcuri; MN Kerbauy; GF Perini; AAF Ribeiro; FPdS Santos; N Hamerschlak; CO Ribeiro;

JOINT USE OF SOLE, CALCINEURIN INHIBITOR-FREE GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS WITH RABBIT ATG AND POSTTRANSPLANT IMMUNOSUPPRESSION WITH CYCLOPHOSPHAMIDE FOR HLA-MATCHED, PERIPHERAL BLOOD TRANSPLANTATION ¿ THE NCT06299462 JURASSIC TRIAL LJ Arcuri; S Maradei; M Roque; EH Atta; S Lermontov; CO Ribeiro;